Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in VTGN — Vistagen Therapeutics, Inc.

CIK 1423053 MIAMI, FL
Back to VTGN Full portfolio

Position in VTGN

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$15,832
+$15,832 QoQ
Shares Held
68,839
Ownership
0.155%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 48 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VTGN Over Time

Shares Held

Position Value (USD)

Derivatives in VTGN

reported options exposure · as of Jun 30, 2026
CallValue
$34,270
CallShares
149,000
PutValue
$3,473
PutShares
15,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,763,744 across 435 Biotechnology names. VTGN ranks #421 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in VTGN

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,473 15,100
2026-06-30 $34,270 149,000
2026-06-30 $15,832 68,839
2026-03-31 $20,349 35,700
2026-03-31 $136,344 239,200
2025-12-31 $306,966 465,100
2025-12-31 $255,156 386,600
2025-09-30 $353,225 99,500
2025-09-30 $861,230 242,600
2025-09-30 $433,320 122,062
2025-06-30 $71,800 35,900
2025-06-30 $134,200 67,100
2025-03-31 $3,000 1,200
2025-03-31 $22,250 8,900
2024-12-31 $161,070 54,600
2024-12-31 $33,040 11,200
2024-09-30 $167,055 55,500
2024-09-30 $968,873 321,885
2024-09-30 $42,140 14,000
2024-06-30 $164,256 47,200
2024-06-30 $100,224 28,800
2024-06-30 $2,191,164 629,645
2024-03-31 $3,927,897 743,920
2024-03-31 $278,784 52,800
2024-03-31 $126,192 23,900
2023-12-31 $198,918 38,700
2023-12-31 $179,386 34,900
2023-12-31 $3,821,564 743,495
2023-09-30 $44,812 8,552
2023-09-30 $262,000 50,000
2023-09-30 $51,352 9,800
2023-06-30 $37,158 19,871
2023-03-31 $2,120 17,674
2022-12-31 $1,189 11,900
2022-12-31 $22,950 229,507
2022-09-30 $5,879 39,200
2022-09-30 $15,839 105,600
2022-09-30 $15,403 102,698
2022-06-30 $98,383 111,800
2022-06-30 $85,623 97,300
2022-06-30 $1,136,064 1,290,983
2022-03-31 $1,295,570 1,044,815
2022-03-31 $37,695 30,400
2022-03-31 $35,835 28,900
2021-12-31 $44,459 22,800
2021-12-31 $265,187 135,994
2021-12-31 $136,304 69,900
2021-09-30 $311,263 113,600
2021-09-30 $345,596 126,130
2021-06-30 $37,658 11,955